364 related articles for article (PubMed ID: 27965018)
1. High content analysis in amyotrophic lateral sclerosis.
Rinaldi F; Motti D; Ferraiuolo L; Kaspar BK
Mol Cell Neurosci; 2017 Apr; 80():180-191. PubMed ID: 27965018
[TBL] [Abstract][Full Text] [Related]
2. Single-cell RNA-seq analysis of the brainstem of mutant SOD1 mice reveals perturbed cell types and pathways of amyotrophic lateral sclerosis.
Liu W; Venugopal S; Majid S; Ahn IS; Diamante G; Hong J; Yang X; Chandler SH
Neurobiol Dis; 2020 Jul; 141():104877. PubMed ID: 32360664
[TBL] [Abstract][Full Text] [Related]
3. Distinct responses of neurons and astrocytes to TDP-43 proteinopathy in amyotrophic lateral sclerosis.
Smethurst P; Risse E; Tyzack GE; Mitchell JS; Taha DM; Chen YR; Newcombe J; Collinge J; Sidle K; Patani R
Brain; 2020 Feb; 143(2):430-440. PubMed ID: 32040555
[TBL] [Abstract][Full Text] [Related]
4. IN VITRO AND IN VIVO MODELS OF AMYOTROPHIC LATERAL SCLEROSIS: AN UPDATED OVERVIEW.
Gois AM; Mendonça DMF; Freire MAM; Santos JR
Brain Res Bull; 2020 Jun; 159():32-43. PubMed ID: 32247802
[TBL] [Abstract][Full Text] [Related]
5. Rapidly progressive amyotrophic lateral sclerosis is associated with microglial reactivity and small heat shock protein expression in reactive astrocytes.
Gorter RP; Stephenson J; Nutma E; Anink J; de Jonge JC; Baron W; Jahreiβ MC; Belien JAM; van Noort JM; Mijnsbergen C; Aronica E; Amor S
Neuropathol Appl Neurobiol; 2019 Aug; 45(5):459-475. PubMed ID: 30346063
[TBL] [Abstract][Full Text] [Related]
6. DREAM-Dependent Activation of Astrocytes in Amyotrophic Lateral Sclerosis.
Larrodé P; Calvo AC; Moreno-Martínez L; de la Torre M; Moreno-García L; Molina N; Castiella T; Iñiguez C; Pascual LF; Mena FJM; Zaragoza P; Y Cajal SR; Osta R
Mol Neurobiol; 2018 Jan; 55(1):1-12. PubMed ID: 28840473
[TBL] [Abstract][Full Text] [Related]
7. Examining the relationship between astrocyte dysfunction and neurodegeneration in ALS using hiPSCs.
Halpern M; Brennand KJ; Gregory J
Neurobiol Dis; 2019 Dec; 132():104562. PubMed ID: 31381978
[TBL] [Abstract][Full Text] [Related]
8. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
9. Studying ALS: Current Approaches, Effect on Potential Treatment Strategy.
Ustyantseva EI; Medvedev SP; Zakian SM
Adv Exp Med Biol; 2020; 1241():195-217. PubMed ID: 32383122
[TBL] [Abstract][Full Text] [Related]
10. Why do motor neurons degenerate? Actualization in the pathogenesis of amyotrophic lateral sclerosis.
Riancho J; Gonzalo I; Ruiz-Soto M; Berciano J
Neurologia (Engl Ed); 2019; 34(1):27-37. PubMed ID: 26853842
[TBL] [Abstract][Full Text] [Related]
11. Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease.
Abdul Wahid SF; Law ZK; Ismail NA; Lai NM
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011742. PubMed ID: 31853962
[TBL] [Abstract][Full Text] [Related]
12. The role of heat shock proteins in Amyotrophic Lateral Sclerosis: The therapeutic potential of Arimoclomol.
Kalmar B; Lu CH; Greensmith L
Pharmacol Ther; 2014 Jan; 141(1):40-54. PubMed ID: 23978556
[TBL] [Abstract][Full Text] [Related]
13. Lack of TNF-alpha receptor type 2 protects motor neurons in a cellular model of amyotrophic lateral sclerosis and in mutant SOD1 mice but does not affect disease progression.
Tortarolo M; Vallarola A; Lidonnici D; Battaglia E; Gensano F; Spaltro G; Fiordaliso F; Corbelli A; Garetto S; Martini E; Pasetto L; Kallikourdis M; Bonetto V; Bendotti C
J Neurochem; 2015 Oct; 135(1):109-24. PubMed ID: 25940956
[TBL] [Abstract][Full Text] [Related]
14. New In Vitro Models to Study Amyotrophic Lateral Sclerosis.
Myszczynska M; Ferraiuolo L
Brain Pathol; 2016 Mar; 26(2):258-65. PubMed ID: 26780562
[TBL] [Abstract][Full Text] [Related]
15. SRSF1-dependent inhibition of C9ORF72-repeat RNA nuclear export: genome-wide mechanisms for neuroprotection in amyotrophic lateral sclerosis.
Castelli LM; Cutillo L; Souza CDS; Sanchez-Martinez A; Granata I; Lin YH; Myszczynska MA; Heath PR; Livesey MR; Ning K; Azzouz M; Shaw PJ; Guarracino MR; Whitworth AJ; Ferraiuolo L; Milo M; Hautbergue GM
Mol Neurodegener; 2021 Aug; 16(1):53. PubMed ID: 34376242
[TBL] [Abstract][Full Text] [Related]
16. Targeting Extracellular Cyclophilin A Reduces Neuroinflammation and Extends Survival in a Mouse Model of Amyotrophic Lateral Sclerosis.
Pasetto L; Pozzi S; Castelnovo M; Basso M; Estevez AG; Fumagalli S; De Simoni MG; Castellaneta V; Bigini P; Restelli E; Chiesa R; Trojsi F; Monsurrò MR; Callea L; Malešević M; Fischer G; Freschi M; Tortarolo M; Bendotti C; Bonetto V
J Neurosci; 2017 Feb; 37(6):1413-1427. PubMed ID: 28011744
[TBL] [Abstract][Full Text] [Related]
17. From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis.
Alrafiah AR
In Vivo; 2018; 32(5):983-998. PubMed ID: 30150420
[TBL] [Abstract][Full Text] [Related]
18. The non-cell-autonomous component of ALS: new in vitro models and future challenges.
Ferraiuolo L
Biochem Soc Trans; 2014 Oct; 42(5):1270-4. PubMed ID: 25233402
[TBL] [Abstract][Full Text] [Related]
19. In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1
Bonifacino T; Provenzano F; Gallia E; Ravera S; Torazza C; Bossi S; Ferrando S; Puliti A; Van Den Bosch L; Bonanno G; Milanese M
Neurobiol Dis; 2019 Sep; 129():79-92. PubMed ID: 31102766
[TBL] [Abstract][Full Text] [Related]
20. Redox system expression in the motor neurons in amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS, superoxide dismutase 1 (SOD1)-mutated familial ALS, and SOD1-mutated ALS animal models.
Kato S; Kato M; Abe Y; Matsumura T; Nishino T; Aoki M; Itoyama Y; Asayama K; Awaya A; Hirano A; Ohama E
Acta Neuropathol; 2005 Aug; 110(2):101-12. PubMed ID: 15983830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
